OrbusNeich Medical Group Holdings Limited

As of December 31, 2025, OrbusNeich Medical Group Holdings Limited carries a market capitalization of 2.98B, placing it among publicly traded companies globally. Its enterprise value stands at 1.32B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

OrbusNeich Medical Group Holdings Limited's next confirmed earnings release is scheduled for March 11, 2027.

As of December 31, 2025, OrbusNeich Medical Group Holdings Limited has 823.25M shares outstanding.

These figures are as of December 31, 2025.

As of December 31, 2025, OrbusNeich Medical Group Holdings Limited maintains a current ratio of 10.54, meaning it holds 10.5x the short-term assets needed to cover near-term liabilities.

These figures cover the twelve months ended December 31, 2025.

As of the close on October 22, 2026, OrbusNeich Medical Group Holdings Limited's stock has declined approximately 17.84% over the past 52 weeks. The 50-day moving average sits at 3.84, while the 200-day moving average is 3.84.

As of December 31, 2025, OrbusNeich Medical Group Holdings Limited holds 1.70B in cash and equivalents against 30.45M in total debt, resulting in a net debt position of -1.70B. Total book value stands at 3.21B, with working capital of 2.47B providing operational flexibility.